Literature DB >> 2917617

Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.

E Sjögren1, G Ruiz-Palacios, B Kaijser.   

Abstract

The presence of different Campylobacter jejuni serotypes in Swedish patients with diarrhoea and in Mexican patients with or without diarrhoea was investigated with special reference to repeated isolations during the course of infection and to symptomatic and asymptomatic episodes. The study included 136 C. jejuni isolates from 62 Mexican children and 173 isolates from 68 Swedish patients. The bacteria were serotyped for heat-stable (HS) and heat-labile (HL) antigen. Swedish patients, all with symptoms, were in general only infected with one serotype and were rarely reinfected. Mexican patients on the other hand were in general infected with mixed serotypes and frequently reinfected without symptoms with new, different serotypes, a finding which is in concordance with a theory of an induced immunity to surface antigens.

Entities:  

Mesh:

Year:  1989        PMID: 2917617      PMCID: PMC2249303          DOI: 10.1017/s0950268800029678

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  35 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

2.  Mucosal and systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation.

Authors:  D H Burr; M B Caldwell; A L Bourgeois; H R Morgan; R Wistar; R I Walker
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  A prospective study of serum antibody responses to enterotoxinogenic Escherichia coli in Swedish travellers.

Authors:  M Jertborn; A M Svennerholm; S Iwarson
Journal:  Scand J Infect Dis       Date:  1988

4.  Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden.

Authors:  A Svedhem; B Kaijser
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

5.  Comparison of different procedures, transport media, and enrichment media for isolation of Campylobacter species from healthy laying hens and humans with diarrhea.

Authors:  E Sjögren; G B Lindblom; B Kaijser
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

6.  Experimental infection of Rhesus monkeys with a human strain of Campylobacter jejuni.

Authors:  R B Fitzgeorge; A Baskerville; K P Lander
Journal:  J Hyg (Lond)       Date:  1981-06

7.  Cohort study of intestinal infection with campylobacter in Mexican children.

Authors:  J J Calva; G M Ruiz-Palacios; A B Lopez-Vidal; A Ramos; R Bojalil
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

8.  Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections.

Authors:  R L Guerrant; R G Lahita; W C Winn; R B Roberts
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

9.  Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand.

Authors:  D N Taylor; P Echeverria; C Pitarangsi; J Seriwatana; L Bodhidatta; M J Blaser
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

10.  Campylobacter enteritis associated with the consumption of free school milk.

Authors:  P H Jones; A T Willis; D A Robinson; M B Skirrow; D S Josephs
Journal:  J Hyg (Lond)       Date:  1981-10
View more
  3 in total

1.  Evaluation of commercial antisera for serotyping heat-labile antigens of Campylobacter jejuni and Campylobacter coli.

Authors:  M A Nicholson; C M Patton
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 2.  Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review.

Authors:  Brian L Pike; Patricia Guerry; Frédéric Poly
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

3.  A systematic review and meta-analysis of Penner serotype prevalence of Campylobacter jejuni in low- and middle-income countries.

Authors:  Tegan N Clarke; Megan A Schilling; Luca A Melendez; Sandra D Isidean; Chad K Porter; Frédéric M Poly
Journal:  PLoS One       Date:  2021-05-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.